Cargando…

Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia

BACKGROUND: Prostatic artery embolization (PAE) has been proved effective in the treatment of lower urinary tracts (LUTS) secondary to benign prostatic hyperplasia (BPH) with low complications, and most of the them are due to non-target embolization of adjacent organs, such as bladder, rectum, semin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jin Long, Yuan, Kai, Wang, Mao Qiang, Yan, Jie Yu, Wang, Yan, Zhang, Guo Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201578/
https://www.ncbi.nlm.nih.gov/pubmed/30355294
http://dx.doi.org/10.1186/s12894-018-0407-7
_version_ 1783365534363942912
author Zhang, Jin Long
Yuan, Kai
Wang, Mao Qiang
Yan, Jie Yu
Wang, Yan
Zhang, Guo Dong
author_facet Zhang, Jin Long
Yuan, Kai
Wang, Mao Qiang
Yan, Jie Yu
Wang, Yan
Zhang, Guo Dong
author_sort Zhang, Jin Long
collection PubMed
description BACKGROUND: Prostatic artery embolization (PAE) has been proved effective in the treatment of lower urinary tracts (LUTS) secondary to benign prostatic hyperplasia (BPH) with low complications, and most of the them are due to non-target embolization of adjacent organs, such as bladder, rectum, seminal vesicles and penis. Aim of this study was to present seminal vesicle (SV) abnormalities following prostatic artery embolization (PAE) for the treatment of symptomatic benign prostatic hyperplasia. METHODS: We reviewed 139 BPH patients who received PAE during the period of February 2009 and January 2015 at a single institution, highlighting seminal vesicle abnormalities and their clinical relevance after PAE. PAE was performed using 90~ 180-μm (mean 100-μm) polyvinyl alcohol foam particles. RESULTS: Nine of 139 patients with SV abnormalities (6.5%) were identified by magnetic resonance imaging (MRI), including subacute haemorrhage in 3 patients and ischaemia in 6 patients. Using cone-beam computed tomography (CB-CT), the seminal vesicle arteries were identified 8 of the 9 patients. All 9 patients complained of a few episodes of mild haematospermia during the 1–4 weeks after PAE; the haematospermia disappeared spontaneously without any treatment. CONCLUSION: SV haemorrhage and ischaemia may occur after PAE, and these patients may present with transient and self-limited haematospermia.
format Online
Article
Text
id pubmed-6201578
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62015782018-10-31 Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia Zhang, Jin Long Yuan, Kai Wang, Mao Qiang Yan, Jie Yu Wang, Yan Zhang, Guo Dong BMC Urol Research Article BACKGROUND: Prostatic artery embolization (PAE) has been proved effective in the treatment of lower urinary tracts (LUTS) secondary to benign prostatic hyperplasia (BPH) with low complications, and most of the them are due to non-target embolization of adjacent organs, such as bladder, rectum, seminal vesicles and penis. Aim of this study was to present seminal vesicle (SV) abnormalities following prostatic artery embolization (PAE) for the treatment of symptomatic benign prostatic hyperplasia. METHODS: We reviewed 139 BPH patients who received PAE during the period of February 2009 and January 2015 at a single institution, highlighting seminal vesicle abnormalities and their clinical relevance after PAE. PAE was performed using 90~ 180-μm (mean 100-μm) polyvinyl alcohol foam particles. RESULTS: Nine of 139 patients with SV abnormalities (6.5%) were identified by magnetic resonance imaging (MRI), including subacute haemorrhage in 3 patients and ischaemia in 6 patients. Using cone-beam computed tomography (CB-CT), the seminal vesicle arteries were identified 8 of the 9 patients. All 9 patients complained of a few episodes of mild haematospermia during the 1–4 weeks after PAE; the haematospermia disappeared spontaneously without any treatment. CONCLUSION: SV haemorrhage and ischaemia may occur after PAE, and these patients may present with transient and self-limited haematospermia. BioMed Central 2018-10-24 /pmc/articles/PMC6201578/ /pubmed/30355294 http://dx.doi.org/10.1186/s12894-018-0407-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhang, Jin Long
Yuan, Kai
Wang, Mao Qiang
Yan, Jie Yu
Wang, Yan
Zhang, Guo Dong
Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
title Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
title_full Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
title_fullStr Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
title_full_unstemmed Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
title_short Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
title_sort seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201578/
https://www.ncbi.nlm.nih.gov/pubmed/30355294
http://dx.doi.org/10.1186/s12894-018-0407-7
work_keys_str_mv AT zhangjinlong seminalvesicleabnormalitiesfollowingprostaticarteryembolizationforthetreatmentofbenignprostatichyperplasia
AT yuankai seminalvesicleabnormalitiesfollowingprostaticarteryembolizationforthetreatmentofbenignprostatichyperplasia
AT wangmaoqiang seminalvesicleabnormalitiesfollowingprostaticarteryembolizationforthetreatmentofbenignprostatichyperplasia
AT yanjieyu seminalvesicleabnormalitiesfollowingprostaticarteryembolizationforthetreatmentofbenignprostatichyperplasia
AT wangyan seminalvesicleabnormalitiesfollowingprostaticarteryembolizationforthetreatmentofbenignprostatichyperplasia
AT zhangguodong seminalvesicleabnormalitiesfollowingprostaticarteryembolizationforthetreatmentofbenignprostatichyperplasia